Jump to content
  • Process Mapping for Managers and Auditors

    Become a confident process mapper. 3rd - 4th July 2018.

    More Info
  • A great place to network

    2018 Annual Conference, Manchester Central, 31 Oct - 2 Nov.

    View Programme
  • Tools to prepare, host and respond to inspections

    GCP Regulatory Inspections Course. 10th - 11th July 2018.

    More Info

Key facts

The number of new RQA members who join the Association each year. We currently have just over 2200 members.

The number of Committee Members in 2018, these volunteers help with everything from new booklets to conference organisation.

The Association is forty years old.

Who are RQA

The research quality association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry.
RQA's purpose is to drive quality and integrity in scientific research.

Read more+

Our Mission

1. To develop and promote quality standards in scientific research.

2. To facilitate knowledge sharing and transfer through:

  • Discussion
  • Training
  • Seminars
  • Forums 
  • Conferences
  • Publications
  • Partnership and co-operation

3. To liaise with regulatory agencies in the development and interpretation of regulations and guidance.

Newsletter

Sign up to the latest news and events.

Latest News

View all news

EMA Guidance

The European Medicines Agency (EMA) and the European Commission have updated their guidance to help pharmaceutical companies prepare for the United Kingdom’s (UK) withdrawal from the European Union (EU).

Read more+

EMA Consultation Document Released 23rd May 2018

Draft guideline on the responsibilities of the sponsor with regard to handling and shipping of investigational medicinal products for human use in accordance with good clinical practice and good manufacturing practice.

Read more+

MHRA Publish 'GxP Data Integrity Guide'

Covering Good Clinical Practice, Good Distribution Practice, Good Laboratory Practice, Good Manufacturing Practice and Good Pharmacovigilance Practice, there has been significant stakeholder interest in the development of the guide. MHRA received over 1300 comments from industry, and trade and professional groups across all GxPs during the consultation process. Such a high degree of engagement required an extended period of review by the MHRA’s GxP data integrity team formed from their GCP, GDP, GLP, GMP and GPvP inspection groups. The GxP data integrity guidance has a high degree of alignment with documents published by other regulators such as PIC/S, WHO, OECD (guidance and advisory documents on GLP) and EMA. It is designed to facilitate compliance through education, whilst clarifying the MHRA’s position on data integrity and the minimum expectation to achieve compliance.

Read more+
Middlesex, South East England
GSK